Previous close | 130.86 |
Open | 131.50 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 131.05 - 131.99 |
52-week range | 74.71 - 138.89 |
Volume | |
Avg. volume | 2,732 |
Market cap | N/A |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | 2.69 |
EPS (TTM) | 0.49 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.